Language: Spanish
References: 6
Page: 116-117
PDF size: 32.79 Kb.

Text Extraction

No abstract

REFERENCES

1. Olvera-Castillo R, Ramos-Espinosa J, García-Cruz AE, Hernández-Zarza NM. Tratamiento antituberculoso ultracorto (2HRZ/2H3R3) versus tratamiento estándar (2HRZ/4H3R3) en combinación fija bajo la estrategia TAES. Rev Inst Nal Enf Resp Mex 2002;15:214-219.

2. Fox W. The chemotherapy of tuberculosis: A review. Chest 1979;76:785-796.

3. Singapore Tuberculosis Service/ British Medical Research Council. Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis: the results up to 30 months. Tubercle 1981;62:95-102.

4. East African and British Medical Research Councils. Controlled clinical trial of five short course (4 month) chemotherapy regimens in pulmonary tuberculosis. First Report of 4th study. Lancet 1978;334-338.

5. East African and British Medical Research Councils. Controlled clinical trial of five short course (4 month) chemotherapy regimens in pulmonary tuberculosis. Second report of the 4th study. Am Rev Respir Dis 1981;123:165-170.

6. Cañedo-Dorantes L. Tamaño de la muestra. En: Cañedo-Dorantes L, editor. Investigación clínica. México: Interamericana, 1987:171-183.